The hen ovary secretes testosterone as the major androgen (Well & Gilbert 1984) . A metabolite of testosterone, 5a-dihydrotestosterone, is also se¬ creted from the hen ovary (Johnson & van Tienhoven 1980; Thies et al. 1983 ). The concentration of testosterone and dihydrotestosterone in the plasma of the hen changes during an ovulatory cycle showing a peak some hours before ovulation (Tanaka & Kamiyoshi 1980; Johnson & van Tienhoven 1980 ), but does not change during a nonlaying period (Tanaka & Kamiyoshi 1980 ). An (Laguë et al. 1975) . Therefore, testosterone and/or dihydrotestosterone are possibly playing a role in the mechanism of LH release for ovulation in the hen. The present study was performed to obtain evidence for the direct action of androgen on the hypothalamus and the pituitary of the hen.
Materials and Methods
ChemicaL· and buffers [3H] R1881 ([3H] methyltrienolone: [:,H] 17ß-hydroxy17a-methyl-4,9,ll-estratrien-3-one; 82 Ci/mmol) and un¬ labelled R1881 were purchased from New England Nu¬ clear Corp (Boston, MA) . The purity of [:iH]R1881 was confirmed by thin-layer chromatography to be more than 98%. Unlabelled testosterone (T), 5a-dihydrotestosterone (DHT), progesterone (P), estradiol (E2) and corti¬ costerone ( ) from Sigma Chemical Corp (St. Louis, MO) were dissolved in absolute ethanol and kept at -20°C until use. Calf thymus DNA, BSA, triamcinolone acetonide and bacitracin were from Sigma Corp, charcoat (Norit A) and protamine sulphate from Nakarai Chemi¬ cals Ltd (Kyoto, Japan), dextran 70 from Pharmacia Fine Chemicals (Uppsala, Sweden), PPO (2, and POPOP (l,4-bis-(2-(5-phenyloxazolyl))) from Wako Pure Chemicals Ltd (Osaka, Japan). All other rea¬ gents were of analytical grade obtained from commercial source.
The buffer solutions used were TEDB ( 10 mmol/1 TrisHCl, 1.5 mmol/1 EDTA, 1 mmol/1 dithiothreitol, and 0.5 mmol/1 bacitracin); TEDBG (TEDB containing 10% (v/v) glycerol); TEDB-KC1 (TEDB containing 0.6 mol/1 KC1); TMD (10 mmol/1 Tris-HCl, 1.5 mmol/1 MgCl,, and 1 mmol/1 dithiothreitol); TMD-Triton (containing 0.25% (v/v) Triton X-100) and TMD-Sucrose (containing 2.4 mol/1 sucrose). All the buffer solutions (pH 7.4 (Fig. 1) . The specific bind- Bound (pmol/1) Changesfollowing an in vivo administration of (Fig. 3) (Dubé & Tremblay 1974) and uropygial gland (Amet et 
